357 related articles for article (PubMed ID: 22343374)
61. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance.
Bosch B; Arenaza-Urquijo EM; Rami L; Sala-Llonch R; Junqué C; Solé-Padullés C; Peña-Gómez C; Bargalló N; Molinuevo JL; Bartrés-Faz D
Neurobiol Aging; 2012 Jan; 33(1):61-74. PubMed ID: 20371138
[TBL] [Abstract][Full Text] [Related]
62. Hippocampal Subfield Atrophies in Converted and Not-Converted Mild Cognitive Impairments Patients by a Markov Random Fields Algorithm.
Vasta R; Augimeri A; Cerasa A; Nigro S; Gramigna V; Nonnis M; Rocca F; Zito G; Quattrone A; For The Alzheimer's Disease Neuroimaging Initiative
Curr Alzheimer Res; 2016; 13(5):566-74. PubMed ID: 26787291
[TBL] [Abstract][Full Text] [Related]
63. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
Hohman TJ; Bell SP; Jefferson AL;
JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
[TBL] [Abstract][Full Text] [Related]
64. Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease.
Mueller SG; Schuff N; Yaffe K; Madison C; Miller B; Weiner MW
Hum Brain Mapp; 2010 Sep; 31(9):1339-47. PubMed ID: 20839293
[TBL] [Abstract][Full Text] [Related]
65. Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: Boundary Shift Integral versus tracing of the entorhinal cortex and hippocampus.
Ezekiel F; Chao L; Kornak J; Du AT; Cardenas V; Truran D; Jagust W; Chui H; Miller B; Yaffe K; Schuff N; Weiner M
Alzheimer Dis Assoc Disord; 2004; 18(4):196-201. PubMed ID: 15592130
[TBL] [Abstract][Full Text] [Related]
66. In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRI.
Pluta J; Yushkevich P; Das S; Wolk D
J Alzheimers Dis; 2012; 31(1):85-99. PubMed ID: 22504319
[TBL] [Abstract][Full Text] [Related]
67. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
[TBL] [Abstract][Full Text] [Related]
68. Lower hippocampal volume predicts decrements in lane control among drivers with amnestic mild cognitive impairment.
Griffith HR; Okonkwo OC; Stewart CC; Stoeckel LE; Hollander JA; Elgin JM; Harrell LE; Brockington JC; Clark DG; Ball KK; Owsley C; Marson DC; Wadley VG
J Geriatr Psychiatry Neurol; 2013 Dec; 26(4):259-66. PubMed ID: 24212246
[TBL] [Abstract][Full Text] [Related]
69. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
70. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.
Jack CR; Shiung MM; Weigand SD; O'Brien PC; Gunter JL; Boeve BF; Knopman DS; Smith GE; Ivnik RJ; Tangalos EG; Petersen RC
Neurology; 2005 Oct; 65(8):1227-31. PubMed ID: 16247049
[TBL] [Abstract][Full Text] [Related]
71. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
[TBL] [Abstract][Full Text] [Related]
72. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease.
Du AT; Schuff N; Amend D; Laakso MP; Hsu YY; Jagust WJ; Yaffe K; Kramer JH; Reed B; Norman D; Chui HC; Weiner MW
J Neurol Neurosurg Psychiatry; 2001 Oct; 71(4):441-7. PubMed ID: 11561025
[TBL] [Abstract][Full Text] [Related]
73. Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment.
Becker JT; Davis SW; Hayashi KM; Meltzer CC; Toga AW; Lopez OL; Thompson PM;
Arch Neurol; 2006 Jan; 63(1):97-101. PubMed ID: 16401741
[TBL] [Abstract][Full Text] [Related]
74. Manual segmentation of the fornix, fimbria, and alveus on high-resolution 3T MRI: Application via fully-automated mapping of the human memory circuit white and grey matter in healthy and pathological aging.
Amaral RSC; Park MTM; Devenyi GA; Lynn V; Pipitone J; Winterburn J; Chavez S; Schira M; Lobaugh NJ; Voineskos AN; Pruessner JC; Chakravarty MM;
Neuroimage; 2018 Apr; 170():132-150. PubMed ID: 27765611
[TBL] [Abstract][Full Text] [Related]
75. Association between executive dysfunction and hippocampal volume in Alzheimer's disease.
Nagata T; Shinagawa S; Ochiai Y; Aoki R; Kasahara H; Nukariya K; Nakayama K
Int Psychogeriatr; 2011 Jun; 23(5):764-71. PubMed ID: 21106135
[TBL] [Abstract][Full Text] [Related]
76. Neuropathological basis of magnetic resonance images in aging and dementia.
Jagust WJ; Zheng L; Harvey DJ; Mack WJ; Vinters HV; Weiner MW; Ellis WG; Zarow C; Mungas D; Reed BR; Kramer JH; Schuff N; DeCarli C; Chui HC
Ann Neurol; 2008 Jan; 63(1):72-80. PubMed ID: 18157909
[TBL] [Abstract][Full Text] [Related]
77. Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.
van de Pol LA; van der Flier WM; Korf ES; Fox NC; Barkhof F; Scheltens P
Neurology; 2007 Oct; 69(15):1491-7. PubMed ID: 17923611
[TBL] [Abstract][Full Text] [Related]
78. Quantitative MR evaluation of atrophy, as well as perfusion and diffusion alterations within hippocampi in patients with Alzheimer's disease and mild cognitive impairment.
Zimny A; Bladowska J; Neska M; Petryszyn K; Guziński M; Szewczyk P; Leszek J; Sąsiadek M
Med Sci Monit; 2013 Feb; 19():86-94. PubMed ID: 23377218
[TBL] [Abstract][Full Text] [Related]
79. Automated 3D segmentation of hippocampus based on active appearance model of brain MR images for the early diagnosis of Alzheimer's disease.
Luo ZR; Zhuang XJ; Zhang RZ; Wang JQ; Yue C; Huang X
Minerva Med; 2014 Apr; 105(2):157-65. PubMed ID: 24727880
[TBL] [Abstract][Full Text] [Related]
80. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
